As of June 2026, 61 paid clinical trials are recruiting in Wynnewood, Pennsylvania. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Wynnewood offers studies at sites including Lankenau Medical Center for conditions such as Breast Cancer, Stage IIIB Lung Cancer AJCC v8, Advanced Lung Non-Small Cell Carcinoma, Anatomic Stage II Breast Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Wynnewood has approximately 61 recruiting research studies across a wide range of therapeutic areas. Pennsylvania hosts UPenn's Perelman School of Medicine and Children's Hospital of Philadelphia — pioneers in CAR-T cell therapy — alongside UPMC, Thomas Jefferson University, and Penn State Hershey.
Researchers run research studies in Wynnewood, PA at 15 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Lankenau Medical Center | Breast Cancer, Stage IIIB Lung Cancer AJCC v8, Advanced Lung Non-Small Cell Carcinoma | 37 |
| Lankenau Institute for Medical Research | Anastomotic Complication, Anastomotic Leak, Anastomotic Leaks | 7 |
| Alliance Cancer Specialists, PC | Breast Cancer, Breast Neoplasms, Esophageal Adenocarcinoma | 3 |
| Lankenau Heart Institute | Atrial Fibrillation, Stroke, Tricuspid Regurgitation | 2 |
| Main Line Health | Endometriosis, Peripheral Arterial Disease, Symptomatic Femoropopliteal Lesions | 2 |
| Alliance Cancer Specialists | Colon Cancer, Colorectal Cancer, Colorectal Cancer (CRC) | 1 |
| Alliance Cancer Specialists, PC, Wynnewood | Solid Tumours | 1 |
| Lankenau Institute for Medical Research (LIMR) | Soft Tissue Lesion | 1 |
| Lankenau Institute of Medical Research | Cardiovascular Diseases, Functional Mitral Regurgitation, Heart Diseases | 1 |
| Lankenau Medical Center/Mainline Medical Center | Stage III Fallopian Tube Cancer, Stage III Ovarian Cancer, Stage III Primary Peritoneal Cancer | 1 |
| Main Line Healh | Pulmonary Embolism | 1 |
| Main Line Health / Lankenau Institute for Medical Research | Tricuspid Regurgitation | 1 |
| Mainline Health Lankenau Institute For Medical Research | Marginal Zone Lymphoma, Relapsed/Refractory Follicular Lymphoma | 1 |
| Site 0277 - Alliance Cancer Specialist, PC | High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer | 1 |
| Tenax Investigational Site | Pulmonary Hypertension Associated With HFpEF | 1 |
Recruiting trials in Wynnewood grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in Pennsylvania are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Pennsylvania research additionally follows state public health department oversight and any applicable state privacy statutes.
Hipa.ai aggregates every recruiting study in Wynnewood from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 61 recruiting clinical trials in Wynnewood, Pennsylvania listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Wynnewood compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Wynnewood include Breast Cancer (5), Stage IIIB Lung Cancer AJCC v8 (4), Advanced Lung Non-Small Cell Carcinoma (2), Anatomic Stage II Breast Cancer AJCC v8 (2), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Wynnewood on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Wynnewood include Lankenau Medical Center, Lankenau Institute for Medical Research, Alliance Cancer Specialists, PC, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Wynnewood are Cancer & tumors (33), Cardiovascular (9), Neurology & pain (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.